Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation.
We have developed an approach for identifying primitive mobilized peripheral blood cells (PBSC) that express high levels of aldehyde dehydrogenase (ALDH). PBSC were stained with a fluorescent ALDH substrate, termed BODIPY trade mark -aminoacetaldehyde (BAAA), and then analysed using flow cytometry. A population of cells with a low side scatter (SSC) and a high level of BAAA staining, termed the SSCloALDHbr population, was readily discriminated and comprised a mean of 3 +/- 5% of leukapheresis samples. A mean of 73 +/- 11% of the SSCloALDHbr population expressed CD34 and 56 +/- 25% of all the mobilized CD34+ cells resided within the SSCloALDHbr population. The SSCloALDHbr population was largely depleted of cells with mature phenotypes and enriched for cells with immature phenotypes. Sorted SSCloALDHbr and SSCloALDHbr CD34+ PBSC were enriched for progenitors with the ability to (1) generate colony-forming units (CFU) and long-term culture (LTC)-derived CFU, (2) expand in primary and secondary LTC, and (3) generate multiple cell lineages. In 21 cancer patients who had undergone autologous PBSC transplantation, the number of infused SSCloALDHbr cells/kg highly correlated with the time to neutrophil and platelet engraftment (P < 0.015 and P < 0.003 respectively). In summary, peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation.
Fallon
Paul
P
Stem Cell Transplant Program, Moffitt Cancer Center, Tampa, FL, StemCo Biomedical, Durham, NC, USA.
Gentry
Tracy
T
Balber
Andrew E
AE
Boulware
David
D
Janssen
William E
WE
Smilee
Renee
R
Storms
Robert W
RW
Smith
Clay
C
D000444:Aldehyde Dehydrogenase / Q000097:blood*; D018929:Cell Culture Techniques / Q000379:methods; D002469:Cell Separation / Q000379:methods; D005434:Flow Cytometry / Q000379:methods; D006085:Graft Survival; D019650:Hematopoietic Stem Cell Mobilization; D006412:Hematopoietic Stem Cells / Q000201:enzymology*; D006801:Humans; D016130:Immunophenotyping; D007937:Leukapheresis; D009369:Neoplasms / Q000201:enzymology / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D012542:Scattering, Radiation
D000444:Aldehyde Dehydrogenase